ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM

THE ROMA (RISK OF OVARIAN MALIGNANCY ALGORITHM) TEST IS A BLOOD TEST USED TO HELP DETERMINE THE LIKELIHOOD OF OVARIAN CANCER IN WOMEN WITH AN ADNEXAL MASS. THIS TEST COMBINES THE LEVELS OF TWO PROTEINS (CA-125 AND HE4) WITH THE PATIENTS MENOPAUSAL STATUS TO GENERATE A SCORE. A HIGHER ROMA SCORE INDICATES A GREATER RISK OF OVARIAN CANCER, WHILE A LOWER SCORE SUGGESTS A LOWER RISK. ITS IMPORTANT TO NOTE THAT ROMA IS NOT A DEFINITIVE DIAGNOSTIC TEST AND SHOULD BE USED IN CONJUNCTION WITH OTHER FACTORS, SUCH AS ULTRASOUND AND CLINICAL SYMPTOMS, TO MAKE A DIAGNOSIS.